These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9751211

  • 1. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
    Sihver W, Fasth KJ, Ogren M, Bivehed H, Bergström M, Nordberg A, Watanabe Y, Långström B.
    J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
    [Abstract] [Full Text] [Related]

  • 2. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.
    Sihver W, Fasth KJ, Ogren M, Lundqvist H, Bergström M, Watanabe Y, Långström B, Nordberg A.
    Nucl Med Biol; 1999 Aug; 26(6):633-40. PubMed ID: 10587101
    [Abstract] [Full Text] [Related]

  • 3. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X, Gong ZH, Fasth KJ, Långström B, Nordberg A.
    Neurochem Int; 1998 Aug; 32(5-6):435-41. PubMed ID: 9676742
    [Abstract] [Full Text] [Related]

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 5. An attempt to visualize baboon brain nicotinic receptors with N-[11C]ABT-418 and N-[11C]methyl-cytisine.
    Valette H, Bottlaender M, Dollé F, Dolci L, Syrota A, Crouzel C.
    Nucl Med Commun; 1997 Feb; 18(2):164-8. PubMed ID: 9076773
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
    Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B.
    J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
    [Abstract] [Full Text] [Related]

  • 7. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C.
    J Med Chem; 1999 Jun 17; 42(12):2251-9. PubMed ID: 10377231
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.
    Badio B, Garraffo HM, Plummer CV, Padgett WL, Daly JW.
    Eur J Pharmacol; 1997 Feb 26; 321(2):189-94. PubMed ID: 9063687
    [Abstract] [Full Text] [Related]

  • 10. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM, Yaksh TL, Taylor P.
    J Pharmacol Exp Ther; 1994 Jul 26; 270(1):159-66. PubMed ID: 8035312
    [Abstract] [Full Text] [Related]

  • 11. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y, Pavlova OA, Chefer SI, Hall AW, Kurian V, Brown LL, Kimes AS, Mukhin AG, Horti AG.
    J Med Chem; 2004 May 06; 47(10):2453-65. PubMed ID: 15115389
    [Abstract] [Full Text] [Related]

  • 12. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 06; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 13. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
    Anderson DJ, Arneric SP.
    Eur J Pharmacol; 1994 Mar 03; 253(3):261-7. PubMed ID: 8200419
    [Abstract] [Full Text] [Related]

  • 14. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.
    J Pharmacol Exp Ther; 1998 May 03; 285(2):777-86. PubMed ID: 9580626
    [Abstract] [Full Text] [Related]

  • 15. Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine.
    Abood LG, Lu X, Banerjee S.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2337-41. PubMed ID: 3606644
    [Abstract] [Full Text] [Related]

  • 16. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP.
    J Pharmacol Exp Ther; 1996 Jan 15; 276(1):289-97. PubMed ID: 8558445
    [Abstract] [Full Text] [Related]

  • 17. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U, Nordberg A.
    Neuroreport; 1995 Nov 27; 6(17):2419-23. PubMed ID: 8747166
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y, Saito K, Imoto M, Ohno T.
    Eur J Pharmacol; 1998 Jun 19; 351(2):181-8. PubMed ID: 9687001
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.
    Saji H, Magata Y, Yamada Y, Tajima K, Yonekura Y, Konishi J, Ohmomo Y, Yokoyama A.
    Chem Pharm Bull (Tokyo); 1992 Mar 19; 40(3):734-6. PubMed ID: 1611685
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
    Kokic M, Honer M, Kessler LJ, Grauert M, Schubiger PA, Ametamey SM.
    J Recept Signal Transduct Res; 2002 Mar 19; 22(1-4):123-39. PubMed ID: 12503611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.